Statin initiation and early stroke recurrence in the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke Trial (POINT) trial population.

Statin initiation and early stroke recurrence in the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke Trial (POINT) trial population. J Stroke Cerebrovasc Dis. 2025 Jul; 34(7):108349.

View in: PubMed

subject areas

Aged
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Ischemic Attack, Transient
Male
Middle Aged
Platelet Aggregation Inhibitors
Protective Factors
Recurrence
Risk Assessment
Risk Factors
Secondary Prevention
Stroke
Time Factors
Treatment Outcome

authors with profiles

Shyam Prabhakaran
James Brorson